慣性聚合 高效追讀感興趣之博客、新聞、科技資訊
閱原文 以慣性聚合開啟

推薦訂閱源

小众软件
小众软件
博客园 - 叶小钗
有赞技术团队
有赞技术团队
大猫的无限游戏
大猫的无限游戏
博客园_首页
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
L
LangChain Blog
Hugging Face - Blog
Hugging Face - Blog
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
aimingoo的专栏
aimingoo的专栏
Blog — PlanetScale
Blog — PlanetScale
爱范儿
爱范儿
T
Tailwind CSS Blog
Jina AI
Jina AI
量子位
Stack Overflow Blog
Stack Overflow Blog
人人都是产品经理
人人都是产品经理
J
Java Code Geeks
V
Visual Studio Blog
月光博客
月光博客

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem CuriosityStream: AI Is Not Enough For An Investment Here Akamai Collapse: Did Anthropic Just Kill Its Prospects? I Think Not Potential $5,000 Monthly Income - 12 Investments To Buy And Hold For The Next 10 Years Citizens Financial Group: Q1 Results Should Validate Recent Strength Weekly Indicators: The Consumer Continues To Spend Like There's No Tomorrow Don't Overlook Arthur J. Gallagher & Co. When Investing Global Ship Lease: Embedded Upside From Charter Repricing And Trade Disruption Marvell: Rating Upgrade On Data Center Boom EMCOR Group: Solid Business That Is Fully Valued High-Yield REITs I Would Trust For Retirement Income Rubrik's Growth Engines Are Working, But 18% Dilution Risk Weighs On The Upside Coeur Mining: The Market Is Still Pricing The Old CDE Morgan Stanley Direct Lending Has Some Issues, But The Price Makes It Buyable Exploring Digital Equity With These 3 Stocks Twin Disc's Pop Means It's Time For A Downgrade Peloton: Great Improvements But With An Idea Lacking Evidence Tap The Brakes And Buy SPLV Clean Up Your Portfolio With Bath & Body Works Devon-Coterra Merger: Good And Bad Tyson Foods: Pivoting Beyond Cyclicality Into Structural Growth
细胞动学公司(Cytokinetics, Incorporated,股票代码CYTK)股东暨分析师会议预拟发言誊录
2026-05-28 · via All Articles on Seeking Alpha

赛托凯耐蒂克斯公司(Cytokinetics, Incorporated)CYTK)股东及分析师电话会议 丙午年五月廿七日午后一时(EDT)

与会诸公

戴安·韦泽(Diane Weiser),职司公司事务之上卿。
约翰·亨德森(John Henderson)
杰弗里·赫塞基尔(Jeffrey Hessekiel) - 副行政总裁、首席法务官及典事
罗伯特·I·布卢姆(Robert I. Blum) —— 首席执行官、总裁及董事

呈述

黛安·韦瑟(Diane Weiser)
企业事务高级副总裁

诸君且安坐,今乃Cytokinetics公司(Cytokinetics)二〇二六年股东年会。仆Diane Weiser,掌司事之大夫。兹告于众:此会已录于牍矣。谨依执事之令。

余今以会议付与Cytokinetics董事会主席约翰·亨德森(John Henderson)。请即发端。

约翰·亨德森(John Henderson)

谨奉谢迪安。诸君请坐。某乃亨德森,司赛特凯奈蒂克斯(Cytokinetics)董事会主席,欣迎诸君赴二〇二六年股东大会。兹宣布开会。

先叙正事之前,请容某介绍公司总裁兼首席执行官罗伯特·布鲁姆(Robert Blum)。待正式议程毕,罗伯特将回顾二零二五年之成就并勾勒二零二六年之规划。

更者,吾乐为诸君引介今日在座之Cytokinetics(细胞动力学)董事会诸同僚:Muna Bhanji(穆娜·班吉)、Jim Daly(吉姆·戴利)、Robert Harrington(罗伯特·哈林顿)、Ed Kaye(埃德·凯)、Bob Landry(鲍勃·兰德里)、Wendell Wierenga(温德尔·维伦加)及Nancy Wysenski(南希·维森斯基)。又,吾亦乐为引介今日亲临之公司企业指导委员会诸同僚:Andrew Callos(安德鲁·卡洛斯),副总裁兼商务长;Isaac Ciechanover(艾萨克·切哈诺弗),副总裁掌公司发展兼商务长;Steve Cook(史蒂夫·库克),高级副总裁掌全球供应链与技事;YulyMae DiNapoli(尤莉梅·迪纳波利),高级副总裁掌人事;Jeff Hessekiel(杰夫·赫塞基尔),副总裁兼法务与行政长;Sung Lee(成·李),副总裁兼财务长;Fady Malik(法迪·马利克),副总裁掌研发;及Christine Murray(克里斯汀·默里),高级副总裁掌全球法规事务。吾亦欲引介安永(Ernst & Young)之Dan Coleman(丹·科尔曼)。与 Young LLP(Young LLP),公司之独立注册公共会计师行也,其人可至。